LGIM Real Assets has secured a 35,000 sq ft letting to biotechnology company Amgen at Cambridge Science Park.
Amgen, which is relocating from another base at the science park, agreed to take three floors on a 10-year lease.
“This letting, agreed during the current lockdown on the March quarter-day, demonstrates the continued interest we are seeing in commercial space within technology and life science centres, despite ongoing uncertainty in the wider market,” said Andrew Mercer, office sector lead at LGIM Real Assets.
Bidwell advised L&G while Cushman & Wakefield advised Amgen.
George Craig, a surveyor in Bidwell’s business space agency team, said: “It’s the biggest Cambridge deal of Q12020 and completed during a week of unprecedented global uncertainty so it’s a real demonstration of the quality of Legal & General’s development and continued confidence in Cambridge Science Park and its enduring science and technology sector.”
